Last Funding Type: Post-IPO Debt
Funding Status: Post-IPO Debt
Headquarters: New York, New York, United States
Founded Date: 1887-01-01
Investor Type: Technology - oriented Investor with Venture Investment Focus
Investment Stage: Early Stage Venture, Venture
Last Funding Date: 2022-02-15
Total Funding: 6080000000
Technology: Biotechnology, Health Care, Medical, Pharmaceutical
Employee Number: 10001+
Number Of Exists: 11
Acquisitions Number: Made Acquisitions
Estimated Revenue: $1B to $10B
Investors Number: 13
Industry: Longevity Biomarkers